The Perfect Storm of Heart Failure and Diabetes: Insights into Pathophysiology and Evidence-Based Treatment Strategies

November 08, 2016

In this educational initiative, experts will address the needs of cardiologists for 1) a grasp of the relationship between DM and HF and the pathophysiology of HF in DM, 2) an explanation of clinical evidence for HF drugs in patients with DM, and 3) an assessment of the profiles of traditional and newer antidiabetic agents in patients with/at risk for cardiovascular disease and interpretation of heart failure-related outcomes.

CME 1.00 Credits

Optimizing Outcomes in the Management of Narcolepsy and Obstructive Sleep Apnea

October 25, 2016

In this program, Michael Thorpy, MD and Phyllis Zee, MD, provide state-of-the-art lectures, a stimulating panel discussion, and a provocative case study to address the challenges in the diagnosis of narcolepsy.

CME 0.75 Credits

Best Practices for Managing Narcolepsy and Obstructive Sleep Apnea: Evidence-Based Strategies and Solutions

June 13, 2016

Thomas Scammell, MD (Chair), Richard Bogan, MD, Michael Thorpy, MD, and Phyllis Zee, MD, PhD address the challenges in the diagnosis of narcolepsy, identify best practices, and assess current and emerging strategies for treatment of EDS in OSA.

CME 2.00 Credits

Improving the Care of Patients with Narcolepsy: Evidence-Based Strategies

June 07, 2015

Michael J. Sateia, MD and Helene A Emsellem, MD and Shalanda L. Mitchell, RPSGT, RST describe best practices in recognition, diagnosis and treatment of narcolepsy.

CE | CME 1.00 Credits

Optimizing Management of Recurrent Angina after PCI

May 08, 2015

Deepak Bhatt, MD, MPH, FSCAI (Chair); Duane Pinto, MD, FSCAI and Peter Stone, MD, MPH conduct a state-of-the-art discussion and case study on recurrent angina after PCI

No Credit Available

Demystifying Hypertriglyceridemia: Taking a Closer Look at Pathophysiology, Etiology, and Treatment

April 29, 2015

Eliot Brinton, MD and Terry Jacobson, MD discuss the pathophysiology, etiology, and treatment of hypertriglyceridemia.

No Credit Available

The Dynamics of In-Hospital and Post-Discharge ACS Management with Oral Antiplatelet Therapies

March 14, 2015

Jeffrey Anderson, MD, Van de Werf,MD and Marc Sabatine MD, discuss timing/location, dosing, duration of oral antiplatelet therapies, clinical trials, and guidelines.

No Credit Available

New Pathways to GLYCEMIC CONTROL: Focus on the Kidney

October 28, 2014

Presentations by Jay Shubrook, DO (Chair), Eugene Cersosimo, MD, PhD, and Robert Henry, MD. discussing the role of glucose regulation and SGLT 2 inhibitors in antihyperglycemic therapy

No Credit Available

Unmasking Narcolepsy: Diagnostic and Therapeutic Strategies

September 19, 2014

Michael Thorpy, MD (Chair) and Allen Boone, RPSGT, RST, CCRC discussion of diagnosis, testing, treatment options and associated clinical efficacy and safety data in narcolepsy management.

No Credit Available

Oral Antiplatelet Therapies for Acute Coronary Syndromes: State of the Art Management

September 15, 2014

Deepak Bhatt, MD, MPH (Chair), Paul Gurbel, MD, Robert Harrington, MD, Ajay Kirtane, MD, SM, Manesh Patel, MD, Marc Sabatine, MD, MPH and Philippe Gabriel Steg, MD discuss contemporary use of antiplatelet therapy and ACS management in lectures and cases.

No Credit Available

Clinical Decision-Making in Narcolepsy Management: State Of The Art

August 19, 2014

Michael Thorpy, MD (Chair); Emmanuel Mignot, MD, PhD; Rafael Pelayo, MD; A. Thomas Perkins, MD, PhD. and Todd Swick, MD. review DSM-5 definitions, ICSD-3 guidelines, treatment options, and challenges in the management of narcolepsy in the pediatric population.

No Credit Available

The Acute Coronary Syndrome Patient: Surveying the Landscape of Antiplatelet Therapy and Best Practices in Secondary Prevention

August 18, 2014

Gregg W. Stone, MD (Chair);Jeffrey S. Berger, MD, MS and Jessica L. Mega, MD, MPH lead discussions on Surveying the landscape of antiplatelet therapy and best practices in secondary prevention

No Credit Available